Balance Sheet
Cash Flow Statement
Daily Values
Growth Metrics
Income Statement
Others
Accumulated Depreciation & AmortizationEBIATLeasesLong-Term Debt IssuancesOther Gross PP&E AdjustmentsProperty, Plant & Equipment (Gross)Receivables - Net
Ratios

Cytokinetics (CYTK) Receivables - Other (2016 - 2019)

Cytokinetics (CYTK) has disclosed Receivables - Other for 10 consecutive years, with $575000.0 as the latest value for Q2 2019.

  • On a quarterly basis, Receivables - Other fell 94.46% to $575000.0 in Q2 2019 year-over-year; TTM through Jun 2019 was $575000.0, a 94.46% decrease, with the full-year FY2018 number at $4.6 million, down 53.09% from a year prior.
  • Receivables - Other was $575000.0 for Q2 2019 at Cytokinetics, down from $2.5 million in the prior quarter.
  • In the past five years, Receivables - Other ranged from a high of $67.0 million in Q3 2016 to a low of $4000.0 in Q2 2015.
  • A 5-year average of $7.9 million and a median of $970000.0 in 2015 define the central range for Receivables - Other.
  • Peak YoY movement for Receivables - Other: plummeted 99.97% in 2015, then soared 142453.19% in 2016.
  • Cytokinetics' Receivables - Other stood at $12000.0 in 2015, then surged by 100.0% to $24000.0 in 2016, then skyrocketed by 40350.0% to $9.7 million in 2017, then tumbled by 53.09% to $4.6 million in 2018, then plummeted by 87.37% to $575000.0 in 2019.
  • Per Business Quant, the three most recent readings for CYTK's Receivables - Other are $575000.0 (Q2 2019), $2.5 million (Q1 2019), and $4.6 million (Q4 2018).